# Lexaria Bioscience Corp. (LEXX) — Gross Profit

## Annual Gross Profit (USD)

| Year | Gross Profit |
| --- | --- |
| 2025 | $703,203 |
| 2024 | $459,456 |
| 2023 | $194,708 |
| 2022 | $183,556 |
| 2021 | $547,392 |
| 2020 | $215,415 |
| 2019 | $199,717 |
| 2018 | $408,102 |
| 2017 | $33,889 |
| 2016 | -$4,897 |

## Quarterly Gross Profit (USD)

| Quarter | Gross Profit |
| --- | --- |
| 2026-02-28 | $20,000 |
| 2025-11-30 | — |
| 2025-05-31 | $174,000 |
| 2025-02-28 | $174,000 |
| 2024-11-30 | $181,203 |
| 2024-05-31 | $84,000 |
| 2024-02-29 | $145,000 |
| 2023-11-30 | $146,456 |
| 2023-05-31 | $64,960 |
| 2023-02-28 | $17,067 |
| 2022-11-30 | $81,940 |
| 2022-05-31 | $81,082 |
| 2022-02-28 | $24,263 |
| 2021-11-30 | $8,310 |
| 2021-05-31 | $144,066 |
| 2021-02-28 | $161,436 |
| 2020-11-30 | $231,178 |
| 2020-05-31 | $16,104 |
| 2020-02-29 | -$20,557 |
| 2019-11-30 | $2,479 |
| 2019-05-31 | $56,835 |
| 2019-02-28 | $12,659 |
| 2018-11-30 | $20,051 |
| 2018-05-31 | $137,913 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/LEXX/gross-profit)